Scarica l'app Stockscreener
1.29
0.00%
0.00
Dopo l'orario di chiusura:
1.32
0.03
+2.33%
Bioaffinity Technologies Inc Borsa (BIAF) Ultime notizie
Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growth2025 Key Lessons & Weekly Momentum Picks - ulpravda.ru
Can bioAffinity Technologies Inc. stock maintain growth trajectoryWeekly Market Summary & Detailed Earnings Play Strategies - ulpravda.ru
Will bioAffinity Technologies Inc. stock attract ESG investorsWeekly Trade Summary & Stock Timing and Entry Methods - ulpravda.ru
Will bioAffinity Technologies Inc. Equity Warrant stock attract ESG investors2025 Fundamental Recap & Daily Chart Pattern Signals - ulpravda.ru
Is bioAffinity Technologies Inc. stock trading at a premium valuationJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - ulpravda.ru
Will bioAffinity Technologies Inc. stock outperform tech sector in 2025Quarterly Growth Report & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peersFundamental Stock Analysis & Small Entry Cost Stocks - ulpravda.ru
bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung - TipRanks
bioAffinity Technologies Maintains CAP Accreditation - TradingView — Track All Markets
Cancer test lab keeps gold-standard accreditation after inspection - Stock Titan
2026 world cup star players explained: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2026 world cup usa national team round of 32 playmakers low block defense odds analysis preview - ulpravda.ru
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 10.8% – Here’s What Happened - Defense World
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 4.9% – Here’s What Happened - Defense World
What drives bioAffinity Technologies Inc Equity Warrant stock priceMarket Liquidity Analysis & High Yield Market Growth - earlytimes.in
Bearish Setup: Will bioAffinity Technologies Inc stock pay special dividendsCPI Data & Weekly Momentum Stock Picks - moha.gov.vn
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership By Investing.com - Investing.com Nigeria
bioAffinity Technologies reports transfer of Village Oaks Pathology ownership - Investing.com
bioAffinity Updates Village Oaks Physician Succession Agreement - TipRanks
bioAffinity Technologies Announces Succession Agreement - TradingView — Track All Markets
Is bioAffinity Technologies Inc. stock a defensive play in 2025Trade Volume Summary & Community Trade Idea Sharing Platform - Улправда
Energy Moves: How bioAffinity Technologies Inc. Equity Warrant stock compares to growth peers2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Will bioAffinity Technologies Inc. stock return to pre crisis levelsJuly 2025 Setups & Free Long-Term Investment Growth Plans - Улправда
Nasdaq Moves: Why bioAffinity Technologies Inc. stock could be next big winnerQuarterly Trade Report & Community Verified Watchlist Alerts - moha.gov.vn
How bioAffinity Technologies Inc. Equity Warrant stock trades during market volatilityJuly 2025 Chart Watch & Free Verified High Yield Trade Plans - Улправда
bioAffinity Technologies Earnings Notes - Trefis
Will bioAffinity Technologies Inc. Equity Warrant stock deliver strong dividend growthWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Market Catalysts: Is bioAffinity Technologies Inc. stock a defensive play in 2025Weekly Investment Recap & Safe Investment Capital Preservation Plans - Улправда
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum - Investing.com Nigeria
bioAffinity Technologies adjourns special shareholder meeting due to lack of quorum By Investing.com - Investing.com South Africa
Why bioAffinity Technologies Inc. Equity Warrant stock appeals to dividend seekers2025 Pullback Review & Fast Entry Momentum Trade Alerts - Улправда
bioAffinity Technologies Adjourns Special Meeting - TradingView — Track All Markets
New Highs: Why bioAffinity Technologies Inc. stock could be next big winner - Улправда
Rate Hike: Can bioAffinity Technologies Inc. stock maintain growth trajectoryQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Is bioAffinity Technologies Inc. Equity Warrant stock dividend yield sustainablePortfolio Return Summary & Advanced Technical Analysis Signals - DonanımHaber
Trading Recap: Can bioAffinity Technologies Inc. Equity Warrant stock sustain revenue growthInsider Buying & AI Forecasted Stock Moves - DonanımHaber
Why bioAffinity Technologies Inc. stock could be next big winnerWeekly Investment Report & Smart Investment Allocation Insights - Улправда
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higherJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
bioAffinity Technologies, Inc. (BIAFW) Fundamental Analysis - Meyka
Reviewing bioAffinity Technologies (NASDAQ:BIAF) and Briacell Therap (NASDAQ:BCTX) - Defense World
Why bioAffinity Technologies Inc. stock could outperform in 2025Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
1,375,102 Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
bioAffinity Technologies Inc trading halted, volatility trading pause - MSN
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire) - Aktiellt
0.37%
2.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):